Related Experiment Videos
Long-term thromboprophylaxis in practice: how can it be implemented?
M T Nurmohamed1, M R MacGillavry
1Department of Rheumatology, Slotervaart Hospital and Free University Hospital, Amsterdam, The Netherlands.
Orthopedics
|June 30, 2000
Summary
Extended use of low-molecular-weight heparins (LMWHs) after surgery helps prevent venous thromboembolism (VTE). An auto-injector device improves LMWH self-administration for patients, enhancing safety and adherence.
Area of Science:
- Medicine
- Pharmacology
- Surgery
Background:
- Prolonging thromboprophylaxis after hospital discharge reduces venous thromboembolism (VTE) incidence.
- Low-molecular-weight heparins (LMWHs) are effective for extended outpatient therapy without monitoring, unlike oral anticoagulants.
- Subcutaneous injection of LMWHs can be a barrier to home use due to administration challenges.
Purpose of the Study:
- To evaluate the use of an auto-injection device for administering LMWH (enoxaparin) for extended thromboprophylaxis.
- To assess the safety, ease of use, and patient acceptance of LMWH self-administration via an auto-injector.
Main Methods:
- Utilized an auto-injection device for precise, pre-determined dosing of enoxaparin.
- Conducted studies with volunteers performing mock injections and patients receiving up to 3 weeks of self-administration.
- Assessed patient acceptance and successful self-administration of the medication.
Main Results:
- The auto-injection device is simple to use and delivers a precise dose.
- Volunteers successfully performed mock injections.
- Patients showed high acceptance of self-administration for up to 3 weeks.
Conclusions:
- An auto-injection device facilitates safe and effective self-administration of LMWH for extended thromboprophylaxis.
- This technology may overcome barriers to home use of LMWHs, improving patient adherence and outcomes.
- Ongoing studies are exploring longer durations of self-administration.